
Twelve years of multiples investors have paid for Chemcon Speciality Chemicals Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Chemcon Speciality Chemicals Ltd trades at a P/E of 30.51× and P/B of 1.49×.
Twelve years of audited numbers for Chemcon Speciality Chemicals Ltd, switchable between annual and quarterly views, consolidated or standalone.
Chemcon Speciality Chemicals Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹718.66 Cr and reported EPS of ₹6.43.
Disclosed business segments at Chemcon Speciality Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Chemcon Speciality Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Chemcon Speciality Chemicals Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Chemcon Speciality Chemicals Ltd's investment case rests on 6 positive markers and 8 flagged concerns drawn from the latest reported filings.
Chemcon exhibits a robust promoter holding of 74.5%, signifying considerable confidence in the company's future and mitigating risks associated with fluctuating external shareholding. This high promoter stake suggests a long-term commitment to the company's success.
Despite recent stock price volatility, Chemcon demonstrates healthy quarterly sales growth of 17.6%, indicating consistent demand for its specialty chemicals. This positive trend suggests a strong market position and potential for continued expansion.
The company maintains a low debt-to-equity ratio of 0.05, indicating financial stability with minimal reliance on debt financing. This strong financial health minimizes the risk of financial distress and enhances investor confidence.
Chemcon boasts a positive operating profit margin (OPM) of 15.5%, highlighting efficient operations and strong pricing power within its niche market. This profitability is a key indicator of the company's ability to generate sustainable returns.
The specialty chemicals sector, where Chemcon operates, is poised for substantial growth driven by increasing demand from diverse end-user industries like pharmaceuticals and agrochemicals, offering significant expansion avenues.
Chemcon's Return on Equity (ROE) of 5% is relatively low compared to industry benchmarks, suggesting that the company may not be utilizing its equity as efficiently as its competitors. This warrants further investigation into capital allocation strategies.
The stock price has shown significant volatility, fluctuating between ₹295 and ₹160 in the past year. This volatility presents a considerable risk for investors seeking portfolio stability.
While quarterly profits have shown some growth (19%), the absolute figures remain modest. The company needs to demonstrate consistent and substantial profit growth to justify its current market capitalization and P/E ratio of 36.30.
Despite a low debt-to-equity ratio, the absolute debt level of ₹24.7 crore might still constrain future growth, especially if the company plans significant expansion or acquisitions. Monitoring debt levels is crucial.
Chemcon's P/E ratio of 36.30 appears high when juxtaposed with its modest Return on Equity (ROE) of 5.00%. This valuation suggests investors are expecting significant future growth, which may not align with current profitability metrics.
Trim if P/E re-rates above 40. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 11.50. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Chemcon Speciality Chemicals Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Chemcon Speciality Chemicals Ltd — derived from the live tape, not yesterday's close.
Chemcon Speciality Chemicals Ltd last traded at ₹194.76 with an intraday range of ₹191.67–₹200.85 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 218.21 | +23.45 | +12.04% |
| R3 | 209.03 | +14.27 | +7.33% |
| R2 | 204.94 | +10.18 | +5.23% |
| R1 | 199.85 | +5.09 | +2.61% |
| PIVOT | 195.76 | 1.00 | 0.51% |
| CURRENT | 194.76 | — | — |
| S1 | 172.31 | -22.45 | -11.53% |
| S2 | 181.49 | -13.27 | -6.81% |
| S3 | 186.58 | -8.18 | -4.20% |
| S4 | 190.67 | -4.09 | -2.10% |
CHEMCON is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 197.75 ~ 200.85
Trading Inside opening range
Daily traded volume and delivery percentage for Chemcon Speciality Chemicals Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Chemcon Speciality Chemicals Ltd stood at 48.1% of traded volume, against a 20-day average of 44.7%.
Filings Chemcon Speciality Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Chemcon Speciality Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 48 documents below.
Chemcon Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board…
Chemcon Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board…
Chemcon Speciality Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Chemcon Speciality Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Chemcon Speciality Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Every dividend, stock split and bonus issue Chemcon Speciality Chemicals has declared, sequenced by announce and record date.
Chemcon Speciality Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Chemcon Speciality Chemicals Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Chemcon Speciality Chemicals Ltd operates in the Basic Materials, listed as NSE: CHEMCON, BSE: 543233.

Chemcon Speciality Chemicals Limited is an Indian company specializing in the manufacturing and sale of specialty chemicals. Their primary markets are pharmaceutical, agrochemical, and the engineering and oilfield chemical sectors, both domestically within India and internationally. The company boasts a long operational history, having been incorporated in 1988 and establishing a strong presence in the Vadodara region.
A significant portion of Chemcon's business involves the production and supply of oilfield chemicals. Their product portfolio in this area includes several types of bromide solutions and powders, such as calcium bromide liquid and powder, sodium bromide solution, and zinc bromide solution. These chemicals play crucial roles in various oilfield operations, contributing to the efficiency and effectiveness of extraction processes.
Chemcon also holds a substantial position in the pharmaceutical chemical market. They manufacture and distribute a range of essential pharmaceutical intermediates and building blocks. Key products in this segment include hexamethyl disilazane, trimethyl chlorosilane, hexamethyl disiloxane, bromobenzene, and chloromethyl isopropyl carbonate. These chemicals serve as vital components in the synthesis of numerous pharmaceuticals, playing a crucial role in the development of life-saving medications.
Beyond oilfield and pharmaceutical chemicals, Chemcon offers a selection of silanes, including hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane. Silanes are versatile chemicals used in various applications, including coatings, adhesives, and sealants, further diversifying Chemcon's product portfolio and market reach. Additionally, the company is involved in the agrochemical sector, providing chemicals that are integral to modern agricultural practices.
In addition to its core manufacturing activities, Chemcon provides contract development and manufacturing services (CDMO). This aspect of their business allows them to collaborate with other companies, offering customized chemical solutions and production capabilities, expanding their operational scope and revenue streams. This service offering showcases their expertise and flexibility within the specialty chemicals industry.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Chemcon Speciality Chemicals Ltd (CHEMCON) is ₹194.76. Today, the stock has declined by ₹0.16 (0.08%), trading in a range of ₹191.67 to ₹200.85. The stock opened at ₹198.9 with a trading volume of 47,207 shares.
Chemcon Speciality Chemicals Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹718.66 crores, P/E ratio of 30.51, ROE of 4.80%, and ROCE of 7.01%. The dividend yield stands at 6.67%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Chemcon Speciality Chemicals Ltd (CHEMCON) is ₹295, while the 52-week low is ₹125. Currently trading at ₹194.76, the stock is 41.0% away from its 52-week low and 34.0% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Chemcon Speciality Chemicals Ltd stock at ₹194.76 depends on multiple factors. The stock is currently trading with a P/E ratio of 30.51 and P/B ratio of 1.49. Today's performance shows a loss of 0.08%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Chemcon Speciality Chemicals Ltd offers a dividend yield of 6.67%, which means for every ₹100 invested at the current price of ₹194.76, you can expect to receive approximately ₹6.67 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Chemcon Speciality Chemicals Ltd's key financial metrics include: P/E Ratio: 30.51, P/B Ratio: 1.49, ROE: 4.80%, ROCE: 7.01%, Dividend Yield: 6.67%, EPS: ₹6.43, Book Value: ₹131.95, and Debt-to-Equity: 11.00. The company's market cap stands at ₹718.66 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Chemcon Speciality Chemicals Ltd stock opened at ₹198.9 and is currently trading at ₹194.76, showing a decline of ₹0.16 (0.08%). The intraday high is ₹200.85 and low is ₹191.67. The trading volume stands at 47,207 shares, indicating moderate market participation today.
Chemcon Speciality Chemicals Ltd has a Price-to-Earnings (P/E) ratio of 30.51, which means investors are willing to pay ₹30.51 for every ₹1 of earnings. With an EPS of ₹6.43, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Chemcon Speciality Chemicals Ltd (CHEMCON) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.